1.
Quadri M, Saitta C, Palamini S, Rebellato S, Watrin T, Tu J-W, Bhatia S, Borkhardt A, Palmi C, Biondi A, Cazzaniga G, Fazio G. Efficacy of the kinase inhibitor CHZ868 against JAK2 rearrangements in pediatric acute lymphoblastic leukemia. Haematologica; https://doi.org/10.3324/haematol.2025.287840 [Early view].